Search

everythinglearnresearchcommunity

for

Search:↓

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Kangfuxin (KFX) extract speeds up wound healing and improves skin regeneration.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

Jojoba roots have unique properties that were previously unexplored.

Juniperus sabina L. extract shows potential medicinal value due to high podophyllotoxin levels and strong anti-butyrylcholinesterase activity.

Indian jujube has many medicinal properties and can help treat ailments like diabetes, inflammation, and cancer.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

CCDC22 and CCDC93 are essential for root and root hair growth in Arabidopsis.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

A 940nm laser effectively reduces inflammation in rat joints.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

A new mutation in the LIPH gene was found to cause a rare hair disorder in a Japanese boy.

Cancer prevention has advanced significantly, with some strategies proving successful.

Vitamin D affects Msx1 protein expression and may influence mineralized tissue health.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

YWS1903 is safe for pregnant rats at moderate doses but causes fetal issues at high doses.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

The 800-nm laser boosts skin collagen production, improving skin structure.

Tofacitinib is a promising treatment for children with rheumatic diseases.